BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 16822701)

  • 1. Streamlining lead discovery by aligning in silico and high-throughput screening.
    Davies JW; Glick M; Jenkins JL
    Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart screening: approaches to efficient HTS.
    Engels MF; Venkatarangan P
    Curr Opin Drug Discov Devel; 2001 May; 4(3):275-83. PubMed ID: 11560058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL
    Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-content screening moves to the front of the line.
    Haney SA; LaPan P; Pan J; Zhang J
    Drug Discov Today; 2006 Oct; 11(19-20):889-94. PubMed ID: 16997138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics.
    Posner BA
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):487-94. PubMed ID: 16022185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
    Fischer HP; Heyse S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTS technologies in biopharmaceutical discovery.
    Wu G; Doberstein SK
    Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput siRNA-based functional target validation.
    Xin H; Bernal A; Amato FA; Pinhasov A; Kauffman J; Brenneman DE; Derian CK; Andrade-Gordon P; Plata-Salamán CR; Ilyin SE
    J Biomol Screen; 2004 Jun; 9(4):286-93. PubMed ID: 15191645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hit and lead generation: beyond high-throughput screening.
    Bleicher KH; Böhm HJ; Müller K; Alanine AI
    Nat Rev Drug Discov; 2003 May; 2(5):369-78. PubMed ID: 12750740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of computational methods in the identification of bioactive compounds.
    Glick M; Jacoby E
    Curr Opin Chem Biol; 2011 Aug; 15(4):540-6. PubMed ID: 21411361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High content cellular screening.
    Rausch O
    Curr Opin Chem Biol; 2006 Aug; 10(4):316-20. PubMed ID: 16793326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-based lead discovery: a chemical update.
    Erlanson DA
    Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTS techniques to investigate the potential effects of compounds on cardiac ion channels at early-stages of drug discovery.
    Netzer R; Bischoff U; Ebneth A
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):462-9. PubMed ID: 12951809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.